Adynxx receives FDA Fast Track designation for AYX1 Injection to treat chronic … – News-Medical.net

by admin on July 18, 2013

Adynxx receives FDA Fast Track designation for AYX1 Injection to treat chronic
News-Medical.net
Adynxx, a clinical-stage pharmaceutical company developing a first-in-class platform of therapeutics to address pain at its molecular roots, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to AYX1 

and more »

View full post on chronic pain – Google News

Previous post:

Next post: